Diagnostics for medicine suitability
Total Trials
2
As Lead Sponsor
As Collaborator
0
Total Enrollment
1,713
NCT05161234
A Clinical Utility Study of PrismRA for Rheumatoid Arthritis
Phase: N/A
Role: Lead Sponsor
Start: Mar 3, 2022
Completion: Dec 6, 2023
NCT06390709
PREDICT Therapy Selection for JAK, T-cell, or IL-6 Inhibitor Therapies Using a Molecular Signature Response Classifier (PREDICT)
Start: Apr 8, 2024
Completion: Dec 31, 2025
Loading map...